Skip to content

Early Mobilization After Pacemaker Implantation.

Early Mobilization After Pacemaker Implantation.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04111354
Acronym
EMAPI
Enrollment
200
Registered
2019-10-01
Start date
2019-03-28
Completion date
2024-08-31
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mobilization, Pacemaker Complication

Keywords

pacemaker, implantation, mobilization, complication

Brief summary

Permanent pacemaker implantation is one of the most common arrhythmological procedure. This procedure is usually accompanied by a minimum of 2-3 days hospitalization, with immobilization of patients (supine) for 16-24 hours. The optimal duration of patient´s immobilization is not determined. There is also no recommendation from individual manufacturers of pacemakers for the duration of immobilization after pacemaker implantation. The length of immobilization is based rather on the tradition established at the time of using electrodes with passive fixation. The aim of our prospective, randomized study (EMAPI) is to compare the safety of short-term (4-hours) immobilization with long-term (16-24 hours) immobilization after primary pacemaker implantation. Septal position will be used for right ventricular electrode.

Interventions

DEVICEPacemaker implantation

Pacemaker implantation

Sponsors

Charles University, Czech Republic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years and older. 2. Indication for permanent pacemaker implantation. 3. Mobile and compliant patient. 4. Willing and able to give written informed consent.

Exclusion criteria

1. Imobile and noncompliant patient. 2. Indication of CRT implantation. 3. Upgrade or revision of implanted devise. 4. Contraindications to pacemaker implantation. 5. Gravidity.

Design outcomes

Primary

MeasureTime frameDescription
Composite endpoint of incidence of adverse events from secondary outcomes depending on the length of immobilization (early vs. late).6 monthsComparsion of incidence of dislodgement of atrial electrode, dislodgement of ventricular electrode in septal position, hematoma surgically treated or requiring blood transfusions, pneumothorax, pocket infection, others complications

Secondary

MeasureTime frameDescription
Incidence of hematoma (surgically treated or requiring blood transfusions.)6 monthscomparsion of early vs. late mobilization
Incidence of pneumothorax.24 hourscomparsion of early vs. late mobilization
Incidence of others complications.6 monthscomparsion of early vs. late mobilization, (mechanical, extracardiac complication etc.)
Incidence of atrial lead dislodgement.6 monthscomparsion of early vs. late mobilization
Incidence of ventricular lead dislodgement.6 monthscomparsion of early vs. late mobilization
Incidence of pocket infection.6 monthscomparsion of early vs. late mobilization

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026